FDA Approves Moderna's mRNA Seasonal Flu Vaccine for Adults 50+
The FDA has granted approval for Moderna's mRNA seasonal flu vaccine, branded as mFLUSIVA, making it available for all adults ages 50 and older. The vaccine's regulatory journey proved unusual—the agency initially declined to review the application before ultimately granting approval.
mFLUSIVA represents Moderna'